STRONTIUM RANELATE PREVENTS RADIOLOGICAL PROGRESSION IN PATIENTS WITH PRIMARY KNEE OSTEOARTHRITIS: A RESPONDERS ANALYSIS

STRONTIUM RANELATE PREVENTS RADIOLOGICAL PROGRESSION IN PATIENTS WITH PRIMARY KNEE OSTEOARTHRITIS: A RESPONDERS ANALYSIS

Opis bibliograficzny
Główni autorzy:	Cooper, C, Berenbaum, F, Nash, P, Zamani, O, Cohen-Solal, M, Bianchi, G, Jaime, B, Navarro, F, Reginster, J
Format:	Conference item
Wydane:	2013

Podobne zapisy

Prevention Of Radiological Progression In Patients With Primary Knee Osteoarthritis With Strontium Ranelate
od: Reginster, J, i wsp.
Wydane: (2013)

Strontium Ranelate Significantly Decreases Radiological Progression Using a New Definition For Radiological Progression In Patients With Primary Knee Osteoarthritis Treated With Strontium Ranelate
od: Bruyere, O, i wsp.
Wydane: (2013)

Effects of Strontium Ranelate On Knee Osteoarthritis Pain: A Responder Analysis
od: Reginster, J, i wsp.
Wydane: (2012)

EFFECT OF STRONTIUM RANELATE ON KNEE PAIN IN OSTEOARTHRITIS: A RESPONDER ANALYSIS
od: Cooper, C, i wsp.
Wydane: (2013)

Clinically meaningful effect of strontium ranelate on symptoms in knee osteoarthritis: a responder analysis.
od: Bruyère, O, i wsp.
Wydane: (2014)

STRONTIUM RANELATE REDUCES THE NUMBER OF RADIOLOGICAL OR RADIOCLINICAL PROGRESSORS IN PATIENTS WITH PRIMARY KNEE OSTEOARTHRITIS
od: Reginster, J, i wsp.
Wydane: (2012)

STRUCTURE MODIFYING EFFECTS OF STRONTIUM RANELATE IN KNEE OSTEOARTHRITIS
od: Reginster, J, i wsp.
Wydane: (2012)

STRONTIUM RANELATE EFFECT ON KNEE OSTEOARTHRITIS PROGRESSION: A MRI ANALYSIS
od: Genant, H, i wsp.
Wydane: (2013)

STRONTIUM RANELATE EFFECT ON KNEE OSTEOARTHRTTIS PROGRESSION
od: Zaim, S, i wsp.
Wydane: (2013)

Clinically Meaningful Effect of Strontium Ranelate On Knee Osteoarthritis Symptoms
od: Bruyere, O, i wsp.
Wydane: (2012)

Strontium Ranelate in Knee Osteoarthritis Trial (SEKOIA): A Structural and Symptomatic Efficacy.
od: Reginster, J, i wsp.
Wydane: (2012)

STRONTIUM RANELATE PREVENTS SPINE OSTEOARTHRITIS PROGRESSION IN PATIENTS WITH PREVALENT SPINAL OSTEOARTHRITIS
od: O Bruyere, i wsp.
Wydane: (2007-08-01)

EFFICACY AND SAFETY OF STRONTIUM RANELATE IN THE TREATMENT OF KNEE OSTEOARTHRITIS: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED INTERNATIONAL TRIAL
od: Reginster, J, i wsp.
Wydane: (2011)

Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: Results of a double-blind, randomised placebo-controlled trial
od: Reginster, J, i wsp.
Wydane: (2012)

Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial.
od: Reginster, J, i wsp.
Wydane: (2013)

Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial
od: Jean-Yves Reginster, i wsp.
Wydane: (2014-02-01)

Efficacy and safety of oral strontium ranelate for the treatment of knee osteoarthritis: rationale and design of randomised, double-blind, placebo-controlled trial.
od: Cooper, C, i wsp.
Wydane: (2012)

STRONTIUM RANELATE DECREASES THE NUMBER OF RAPID RADIOLOGICAL PROGRESSORS FROM THE FIRST YEAR IN SEKOIA STUDY
od: Chevalier, X, i wsp.
Wydane: (2014)

Efficacy and safety of oral strontium ranelate for the treatment of knee osteoarthritis: rationale and design of randomised, double-blind, placebo-controlled trial
od: Cyrus Cooper, i wsp.
Wydane: (2013-12-01)

PATHOGENESIS OF OSTEOARTHRITIS AND SUBSTANTIATION OF THE USE OF STRONTIUM RANELATE
od: Elena Mikhailovna Zaitseva, i wsp.
Wydane: (2014-02-01)

STRONTIUM RANELATE: WHAT THE FUTURE HOLDS
od: Cooper, C
Wydane: (2011)

STRONTIUM RANELATE INCREASES THE NUMBER OF PATIENTS WITH IMPROVEMENT IN OSTEOARTHRITIS SYMPTOMS COMPARED TO PLACEBO IN THE SEKOIA STUDY
od: Bruyere, O, i wsp.
Wydane: (2013)

Strontium ranelate as a possible disease-modifying osteoarthritis drug: a systematic review
od: T.A. Rodrigues, i wsp.
Wydane: (2018-06-01)

EFFICACY AND SAFETY OF STRONTIUM RANELATE IN THE TREATMENT OF MALE OSTEOPOROSIS
od: J M Kaufman, i wsp.
Wydane: (2012-08-01)

Long treatment with strontium ranelate of womenwith postmenopausal osteoporosis: 10-year results
od: J Y Reginster, i wsp.
Wydane: (2011-04-01)

STRONTIUM RANELATE IS THE DRUG OF CHOICE IN THE TREATMENT OF OSTEOPOROSIS
od: Nataliya Vladimirovna Toroptsova
Wydane: (2010-09-01)

Strontium ranelate is a drug to treat osteoarthrosis
od: Oksana Anatolyevna Nikitinskaya
Wydane: (2013-03-01)

STRONTIUM RANELATE IS THE DRUG OF CHOICE IN THE TREATMENT OF OSTEOPOROSIS
od: Nataliya Vladimirovna Toroptsova
Wydane: (2010-09-01)

STRONTIUM RANELATE DECREASES VERTEBRAL FRACTURE RISK WHATEVER THE LEVEL OF PRETREATMENT BONE TURNOVER MARKERS
od: J COLLETTE, i wsp.
Wydane: (2007-08-01)

STRONTIUM RANELATE AND RISK OF VENOUS THROMBOEMBOLISM (VTE): AN UPDATE OF A RETROSPECTIVE COHORT STUDY IN THE UK GENERAL PRACTICE RESEARCH DATABASE (GPRD)
od: Cooper, C, i wsp.
Wydane: (2012)

Strontium ranelate's dual action: A closer look
od: Russell, R
Wydane: (2006)

Bivalos (strontium ranelate) administration experience in postmenopausal osteoporosis
od: I A Skripnikova, i wsp.
Wydane: (2009-04-01)

Strontium ranelate in the treatment of osteoporosis: evidence for its efficacy
od: N V Toroptsova, i wsp.
Wydane: (2010-02-01)

Pathogenetic treatment with strontium ranelate in women with postmenopausal osteoporosis
od: Olga Borisovna Yershova
Wydane: (2010-12-01)

How to define responders in osteoarthritis.
od: Cooper, C, i wsp.
Wydane: (2013)

THE PLACE OF STRONTIUM RANELATE IN THE TREATMENT OF PATIENTS WITH OSTEOPOROSIS (RESULTS OF THE MARC PROGRAM)
od: O. A. Nikitinskaya, i wsp.
Wydane: (2018-09-01)

Strontium ranelate in the treatment of postmenopausal osteoporosis: results of administration in clinical practice
od: N V Toroptsova, i wsp.
Wydane: (2008-06-01)

Effect of Strontium Ranelate on Condylar Growth during Mandibular Advancement in Rats
od: Hasan Camcı, i wsp.
Wydane: (2020-12-01)

Strontium ranelate inhibits wear particle-induced aseptic loosening in mice
od: Tianxiang Geng, i wsp.
Wydane: (2018-07-01)

The Comparison of the Effect of Risedronate and Strontium Ranelate on Bone Mineral Density in Postmenopausal Women
od: Figen Yılmaz, i wsp.
Wydane: (2012-08-01)